CoChat

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

Open access
Yamasaki, Kazumi, Tateyama, Masakuni, Abiru, Seigo, Komori, Atsumasa, Nagaoka, Shinya, Saeki, Akira, Hashimoto, Satoru, Sasaki, Ryu, Bekki, Shigemune, Kugiyama, Yuki, Miyazoe, Yuri, Kuno, Atsushi, Korenaga, Masaaki, Togayachi, Akira, Ocho, Makoto, Mizokami, Masashi, Narimatsu, Hisashi, Yatsuhashi, Hiroshi · 2014 · Hepatology
Cited by 232

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The Wisteria floribunda agglutinin-positive human Mac-2-binding protein (WFA+-M2BP) was recently shown to be a liver fibrosis glycobiomarker with a unique fibrosis-related glycoalteration. We evaluated the ability of WFA+-M2BP to predict the development of hepatocellular carcinoma (HCC) in patients who were infected with the hepatitis C virus (HCV). A total of 707 patients who had been admitted to our hospital with chronic HCV infection without other potential risk factors were evaluated to determine the ability of WFA+-M2BP to predict the development of HCC; factors evaluated included age, sex, viral load, genotypes, fibrosis stage, aspartate and alanine aminotransferase levels, bilirubin, albumin, platelet count, alpha-fetoprotein (AFP), WFA+-M2BP, and the response to interferon (IFN) therapy. Serum WFA+-M2BP levels were significantly increased according to the progression of liver fibrosis stage ( P < 0.001). In each distinctive stage of fibrosis (F0-F1, F2, F3, and F4), the risk of development of HCC was increased according to the elevation of WFA+-M2BP. Multivariate analysis identified age > 57 years, F4, AFP > 20 ng/mL, WFA+-M2BP ≥4, and WFA+-M2BP 1-4 as well as the response to IFN (no therapy vs. sustained virological response) as independent risk factors for the development of HCC. The time-dependent areas under the receiver operating characteristic curve demonstrated that the WFA+-M2BP assay predicted the development of HCC with higher diagnostic accuracy than AFP. Conclusion : WFA+-M2BP can be applied as a useful surrogate marker for the risk of HCC development, in addition to liver biopsy. (Hepatology 2014;60:1563–1570)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.27305

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 232

Metadata

Authors
Yamasaki, K., Tateyama, M., Abiru, S., Komori, A., Nagaoka, S., Saeki, A., Hashimoto, S., Sasaki, R., Bekki, S., Kugiyama, Y., Miyazoe, Y., Kuno, A., Korenaga, M., Togayachi, A., Ocho, M., Mizokami, M., Narimatsu, H., & Yatsuhashi, H.
Venue
Hepatology
Published
2014-11
Volume
60
Issue
5
Pages
1563-1570
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1971891809
Cited by
232
References
35
FWCI
11.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. https://app.cochat.ai/papers/10.1002/hep.27305
The paper
Yamasaki, K., Tateyama, M., Abiru, S., Komori, A., Nagaoka, S., Saeki, A., Hashimoto, S., Sasaki, R., Bekki, S., Kugiyama, Y., Miyazoe, Y., Kuno, A., Korenaga, M., Togayachi, A., Ocho, M., Mizokami, M., Narimatsu, H., & Yatsuhashi, H. (2014). Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. https://doi.org/10.1002/hep.27305

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.